FDA-Approved CBD Drug Shows Early Promise in Anorexia Patients

By |2026-04-10T03:04:36+01:0010 April 2026|

A small pilot study has found preliminary evidence to suggest that the FDA-approved CBD formulation, Epidiolex, may have benefits for weight restoration and symptom improvement in anorexia patients.  Anorexia Nervosa (AN) is a severe mental illness, marked by an intense fear of gaining weight and persistent [...]

Comments Off on FDA-Approved CBD Drug Shows Early Promise in Anorexia Patients

Cannabis Biopharma Company Enters Fight Over CMS Hemp Pilot

By |2026-04-10T03:04:21+01:0010 April 2026|

A cannabis biopharma company is seeking to join the federal lawsuit challenging the Centers for Medicare & Medicaid Services’ (CMS) new hemp and CBD pilot program, adding a pharmaceutical voice to a government-sanctioned program allowing untested and unregulated hemp products into the marketplace. MMJ International Holdings [...]

Comments Off on Cannabis Biopharma Company Enters Fight Over CMS Hemp Pilot